Relationship between the expression of cyclooxygenase 2 and MDR1/P-glycoprotein in invasive breast cancers and their prognostic significance
Open Access
- 25 August 2005
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research
- Vol. 7 (5) , R862-70
Abstract
Introduction: Recent reports suggest that expression of the cyclooxygenase 2 (COX-2) enzyme may up-regulate expression of MDR1/P-glycoprotein (MDR1/P-gp), an exponent of resistance to cytostatic drugs. The present study aimed at examining the relationship between the expression of COX-2 and of MDR1/P-gp in a group of breast cancer cases. Methods: Immunohistochemical reactions were performed using monoclonal antibodies against COX-2 and MDR1/P-gp on samples originating from 104 cases of primary invasive breast cancer. Results: COX-2-positive cases were shown to demonstrate higher expression of MDR1/P-gp (P < 0.0001). The studies also demonstrate that COX-2 expression was typical for cases of a higher grade (P = 0.01), a shorter overall survival time (P < 0.0001) and a shorter progression-free time (P < 0.0001). In the case of MDR1/P-gp, its higher expression characterised cases of a higher grade (P < 0001), with lymph node involvement (P < 0001), and shorter overall survival (P < 0.0001) and progression-free time (P < 0.0001). Conclusion: Our studies confirmed the unfavourable prognostic significance of COX-2 and MDR1/P-gp. We also document a relationship between COX-2 and MDR1/P-gp, which suggests that COX-2 inhibitors should be investigated in trials as a treatment supplementary to chemotherapy of breast cancers.Keywords
This publication has 30 references indexed in Scilit:
- RNA expression of MDR1/P-glycoprotein, DNA-topoisomerase I, and MRP2 in ovarian carcinoma patients: correlation with chemotherapeutic responseGynecologic Oncology, 2004
- Expression of COX‐2, mPGE‐synthase1, MDR‐1 (P‐gp), and Bcl‐xL: a molecular pathway of H pylori‐related gastric carcinogenesisThe Journal of Pathology, 2004
- Regulation of MDR-1 (P-glycoprotein) by Cyclooxygenase-2Journal of Biological Chemistry, 2002
- Expression of Cyclooxygenase 2 Is an Independent Prognostic Factor in Human Ovarian CarcinomaThe American Journal of Pathology, 2002
- Multidrug resistance in cancer: role of ATP–dependent transportersNature Reviews Cancer, 2002
- Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2002
- National Institutes of Health Consensus Development Conference Statement: Adjuvant Therapy for Breast Cancer, November 1-3, 2000JNCI: Journal of the National Cancer Institute, 2001
- Expression of Multidrug Resistance‐related Transporters in Human Breast CarcinomaJapanese Journal of Cancer Research, 2001
- Expression of Cyclooxygenase-2 in Human Transitional Cell Carcinoma of the Urinary BladderThe American Journal of Pathology, 2001
- pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐upHistopathology, 1991